Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd
is in the business of trading of Pacemakers.[1]
- Market Cap ₹ 69.4 Cr.
- Current Price ₹ 185
- High / Low ₹ 283 / 90.0
- Stock P/E 21.4
- Book Value ₹ 48.3
- Dividend Yield 0.00 %
- ROCE 23.7 %
- ROE 19.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Promoter holding has increased by 4.74% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 36.4%
- Company has high debtors of 180 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.89 | 7.44 | 6.94 | 6.80 | 7.28 | 8.77 | 7.56 | 9.23 | 20.26 | 22.04 | 16.68 | 21.62 | 21.19 | |
| 5.86 | 6.37 | 6.39 | 5.88 | 6.50 | 7.57 | 6.62 | 7.45 | 14.81 | 16.16 | 14.34 | 16.31 | 15.93 | |
| Operating Profit | 1.03 | 1.07 | 0.55 | 0.92 | 0.78 | 1.20 | 0.94 | 1.78 | 5.45 | 5.88 | 2.34 | 5.31 | 5.26 |
| OPM % | 14.95% | 14.38% | 7.93% | 13.53% | 10.71% | 13.68% | 12.43% | 19.28% | 26.90% | 26.68% | 14.03% | 24.56% | 24.82% |
| 0.03 | 0.02 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.10 | 0.14 | 0.12 | 0.12 | 0.13 | |
| Interest | 0.42 | 0.37 | 0.40 | 0.32 | 0.32 | 0.38 | 0.35 | 0.29 | 0.30 | 0.45 | 0.61 | 0.48 | 0.32 |
| Depreciation | 0.76 | 0.77 | 0.65 | 0.42 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.95 | 0.81 | 0.74 | 0.74 |
| Profit before tax | -0.12 | -0.05 | -0.45 | 0.19 | 0.25 | 0.35 | 0.13 | 1.06 | 4.62 | 4.62 | 1.04 | 4.21 | 4.33 |
| Tax % | -58.33% | 60.00% | -26.67% | 31.58% | 44.00% | 31.43% | 61.54% | 26.42% | 29.44% | 27.49% | 27.88% | 25.42% | |
| -0.06 | -0.09 | -0.32 | 0.13 | 0.14 | 0.24 | 0.05 | 0.78 | 3.26 | 3.36 | 0.75 | 3.14 | 3.24 | |
| EPS in Rs | -0.17 | -0.25 | -0.89 | 0.36 | 0.39 | 0.67 | 0.14 | 2.17 | 9.06 | 9.33 | 2.08 | 8.37 | 8.79 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 43% |
| 5 Years: | 129% |
| 3 Years: | -1% |
| TTM: | 215% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 77% |
| 3 Years: | -19% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 21% |
| 3 Years: | 18% |
| Last Year: | 20% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.75 |
| Reserves | 1.77 | 1.68 | 1.36 | 1.60 | 1.74 | 1.98 | 2.03 | 2.81 | 6.07 | 9.43 | 10.18 | 14.36 |
| 2.78 | 1.97 | 2.71 | 2.93 | 3.91 | 3.33 | 3.20 | 3.05 | 2.19 | 4.30 | 5.08 | 2.68 | |
| 0.95 | 1.35 | 1.16 | 1.33 | 1.35 | 2.08 | 2.15 | 2.72 | 4.68 | 4.42 | 4.19 | 4.92 | |
| Total Liabilities | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 21.75 | 23.05 | 25.71 |
| 3.13 | 2.55 | 2.02 | 1.88 | 2.40 | 2.47 | 2.69 | 2.56 | 3.12 | 4.24 | 3.87 | 3.81 | |
| CWIP | 0.00 | 0.00 | 0.77 | 0.99 | 1.25 | 1.81 | 1.64 | 1.65 | 1.66 | 0.93 | 0.93 | 0.93 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 5.97 | 6.05 | 6.04 | 6.59 | 6.95 | 6.71 | 6.65 | 7.97 | 11.76 | 16.58 | 18.25 | 20.97 | |
| Total Assets | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 21.75 | 23.05 | 25.71 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.47 | 1.35 | 0.42 | 1.13 | 0.31 | 2.25 | 1.09 | 1.76 | 1.69 | -0.04 | -0.01 | 2.92 | |
| -0.49 | -0.18 | -0.86 | -0.52 | -1.01 | -1.00 | -0.53 | -1.19 | -1.41 | -1.67 | -0.04 | -0.78 | |
| 0.20 | -1.14 | 0.22 | -0.50 | 0.36 | -1.17 | -0.31 | -0.45 | -1.10 | 1.75 | 0.19 | -1.61 | |
| Net Cash Flow | 0.18 | 0.03 | -0.22 | 0.10 | -0.34 | 0.08 | 0.25 | 0.12 | -0.82 | 0.04 | 0.14 | 0.54 |
| Free Cash Flow | -0.02 | 1.15 | -0.46 | 0.63 | -0.72 | 1.13 | 0.53 | 1.42 | 0.49 | -1.38 | -0.73 | 1.69 |
| CFO/OP | 54% | 126% | 98% | 123% | 45% | 192% | 135% | 106% | 48% | 19% | 47% | 72% |
Ratios
Consolidated / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 70.99 | 88.31 | 113.08 | 143.32 | 152.92 | 134.01 | 145.81 | 127.73 | 84.85 | 77.17 | 145.08 | 179.63 |
| Inventory Days | 670.58 | 359.32 | 243.33 | 301.93 | 276.44 | 216.62 | 272.02 | 194.20 | 157.41 | 285.83 | 463.17 | 275.46 |
| Days Payable | 29.71 | 32.67 | 18.86 | 49.65 | 37.10 | 54.15 | 48.57 | 17.55 | 32.22 | 12.45 | 57.32 | 60.45 |
| Cash Conversion Cycle | 711.86 | 414.96 | 337.55 | 395.60 | 392.26 | 296.48 | 369.25 | 304.38 | 210.04 | 350.55 | 550.93 | 394.64 |
| Working Capital Days | 107.01 | 116.27 | 110.97 | 107.35 | 100.27 | 42.87 | 37.66 | 23.33 | 63.06 | 101.68 | 157.77 | 180.31 |
| ROCE % | 3.56% | 4.16% | -0.80% | 6.46% | 5.06% | 7.93% | 5.30% | 14.43% | 46.15% | 34.74% | 9.12% | 23.66% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Cumulative pacemaker implants count ・Standalone data |
|
|||||
| India revenue share (domestic vs export mix) % ・Standalone data |
||||||
| Number of permanent employees count ・Standalone data |
||||||
| R&D expenditure INR lakhs ・Standalone data |
||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- M/s Agarwal Patel & Sinhal appointed statutory auditors for five years from 29 September 2026.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
- Shareholders approved reappointment of JMD Akash Sethi and Independent Directors Manali Tongia, Somya Chhabra at 38th AGM.
-
Announcement under Regulation 30 (LODR)-Change in Management
- 38th AGM approved reappointment of JMD Akash Sethi and independent directors Manali Tongia, Somya Chhabra.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Declaration Of Results Of Remote E-Voting And E-Voting At The AGM In Compliance With The Regulation 44 (3) Of SEBI (LODR) Regulation, 2015 And Scrutinizer'S Report In Relation To The 38Th AGM Held On 29Th September, 2026
- 38th AGM voting results and scrutinizer report released for 29 September 2026 resolutions.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
SPL is in the business of delivering MRI safe life saving critical medical devices that regulate heart rhythms and improve the quality of life for patients suffering from cardiac conditions
such as arrhythmias and heart failure.